Outcome of unrelated bone marrow donor searches in 174 children resulting in 45 patients transplanted in the HLA-matched and -mismatched situation

Bone Marrow Transplantation

Volumn 26, Issue 1, 2000, Pages 31-43

  Souillet, G ^a   Rey, S ^b   Bertrand, Y ^a   Pujol, M ^a   Pondarre C ^a   Bourgeot, J P ^c   Raba, M ^d   Eljaafari, A ^c   Chapuis, F ^e   Manel, A M ^a   Philippe, N ^a   Gebuhrer, L ^b  

^a HÔPITAL DEBROUSSE   (France)

^b Histocompatibility Laboratory   (France)

^c Cell Therapy Research Institute   (France)

^d ETABLISSEMENT FRANÇAIS DU SANG   (France)

^e HOSPICES CIVILS DE LYON   (France)

Author keywords

Donor search; HLA mismatch; Pediatric BMT; Thymoglobuline; Unrelated donors

Indexed keywords

THYMOCYTE ANTIBODY;

ADOLESCENT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CONDITIONING; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELAPSE; SURVIVAL; TREATMENT OUTCOME; UMBILICAL CORD BLOOD;

EID: 0033923820     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702460     Document Type: Article

References (52)

1. Stroncek D, Bartsh G, Perkins HA et al. The National Marrow Donor Program. Transfusion 1993; 33: 567-577.
2. Cleaver SA. The Anthony Nolan Research Centre. Bone Marrow Transplant 1993; 11 (Suppl. 1): 38-40.
3. Raffoux C, Gluckman E, Busson M et al. Development of a National Volunteer Donors File for Bone Marrow Transplantation. Bone Marrow Transplant 1988; 3 (Suppl. 1): 163-164.
4. Hansen JA, Clift RA, Thomas ED et al. Transplantation of marrow from an unrelated donor to a patient with leukemia. New Engl J Med 1980; 303: 565-567.
5. Beatty PG, Clift RA, Mickelson EM et al. Marrow transplantation from unrelated donors other than HLA identical siblings. New Engl J Med 1985; 313: 765-771.
6. Hows JM, Yin JL, March J et al. Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia. Blood 1986; 68: 1322-1328.
7. Beatty PG, Ash R, Hows JM, McGlave PB. The use of unrelated bone marrow donors in the treatment of patients with chronic myelogenous leukemia: experience of four marrow transplant centers. Bone Marrow Transplant 1989; 4: 287-290.
8. McGlave PB, Beatty PG, Ash R, Hows JM. Therapy of chronic myelogenous leukemia with unrelated donor bone marrow transplantation: results in 102 cases. Blood 1990; 75: 1728-1732.
9. Kernan NA. Outcome of 459 marrow transplants derived from unrelated donors for treatment of acquired and congenital lymphohematopoietic disorders or metabolic disorders: initial report from the National Marrow Donor Program. Blood 1991; 78 (Suppl. 1): (Abstr. 77a).
10. Beatty PG, Hansen JA, Longton GM et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 1991; 51: 443-447.
11. Casper J, Camitta B, Truitt R et al. Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia. Blood 1995; 85: 2354-2363.
12. Balduzzi A, Gooley T, Anasetti C et al. Unrelated donor marrow transplantation in children. Blood 1995; 86: 3247-3256.
13. Gringrich RD, Ginder GD, Goeken NE et al. Allogeneic marrow grafting with partially mismatched unrelated donors. Blood 1988; 71: 1375-1381.
14. Anasetti C, Beatty PG, Storb R et al. Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol 1990; 29: 79-91.
15. Souillet G, Gebuhrer L, Bertrand Y et al. Half a part of unrelated BMT in HLA mismatch situation for 45 children: comparison of the results. Bone Marrow Transplant 1998; 21 (Suppl. 1): S30 (Abstr. 107).
16. Oudshoorn M, Van Leeuwen A, v d Zanden HGM, Van Rood JJ on behalf of the Editorial Board of BMDW Bone Marrow Donors World Wide. A successful exercise in international cooperation. Bone Marrow Transplant 1994; 14: 3-8.
17. Gebuhrer L, Betuel H, Lambert J et al. A division of HLA-DQw1 associated with DR1, DR1x-DQw1, DR2 short, DRw10, and DRw14. I. Definition by alloantiserum LY1327. Hum Immunol 1987; 18: 235-245.
18. Tiercy JM, Gorski J, Betuel H et al. DNA typing of DRw6 subtypes: correlation with DRB1 and DRB3 allelic sequences by hybridization with oligonucleotide probes. Hum Immunol 1989; 24: 1-14.
19. Tiercy JM, Morel C, Freidel AC et al. Selection of unrelated donors for bone marrow transplantation is improved by HLA class II genotyping with oligonucleotide hybridization. Proc Natl Acad Sci USA 1991; 1988: 7121-7125.
20. Levine J, Yang Y. SSOP typing of the 10th International Histocompatibility Workshop: Reference Cell Lines for HLA-C Alleles. Tiss Antigen 1994; 44: 174-183.
21. Tonks S, Marsh SGE, Bunce M et al. HLA class 1 DNA study. In: Charron D (ed). HLA, vol 1. EDK Medical and Scientific: Sevres, 1997, pp 199-215.
22. Tiercy JM, Gebuhrer L, Betuel H et al. A new HLA-DR4 allele with a DR11 alpha-helix sequence. Tiss Antigen 1993; 41: 97-101.
23. Gebuhrer L, Adami N, Javaux F et al. Sequence of a new HLA-DR4 allele with an unusual residue at position 88 that does not seem to affect T cell allorecognition. Hum Immunol 1996; 51: 60-62.
24. Grundschober C, Labonne MP, Javaux F et al. Sequence of four new HLA-Cw alleles: a possible role of interallelic recombination. Tiss Antigen 1998; 51: 72-79.
25. Steven GE, Marsh for the WHO Nomenclature Committee for Factors of the HLA System. Nomenclature for factors of the HLA system. Update July 1998. Tiss Antigen 1998; 59: 748-749.
26. Freidel AC, Betuel H, Gebuhrer L et al. Cellular and serological subtypes of HLA DR2. Tiss Antigens 1987; 296: 129-140.
27. Bordigoni P, Esperou H, Souillet G et al. Total body irradiation-high dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy : a Société Française de Greffe de Moelle study. Br J Haematol 1998; 102: 656-665.
28. + cells. Bone Marrow Transplant 1997; 19 (Suppl. 1): S82 (Abstr. 0326).
29. Trigg ME, Gingrich R, Goeken N et al. Low rejection rate when using unrelated or haploidentical donors for children with leukemia undergoing marrow transplantation. Bone Marrow Transplant 1989; 4: 431-437.
30. Cavazzana-Calvo M, Jabado N, Bordigoni P et al. In vivo infusion of anti-LFA-1 and anti-CD2 antibodies prevents graft failure after HLA partially incompatible bone marrow transplantation in children with high risk acute lymphoblastic leukaemia. Leuk Lymphoma 1997; 28: 103-112.
31. Cahn JY, Bordigoni P, Souillet G et al. The TAM regimen prior to allogeneic and autologous bone marrow transplantation for high-risk acute lymphoblastic leukemias: a cooperative study of 62 patients. Bone Marrow Transplant 1991; 7: 1-4.
32. Talbot DC, Powles RL, Sloane JP et al. Cyclosporine-induced graft-versus-host disease following autologous bone marrow transplantation in acute myeloid leukaemia. Bone Marrow Transplant 1990; 6: 17-20.
33. Reiffers J, Trouette R, Marit G et al. Autologous blood stem cell transplantation for chronic granulocytic leukaemia in transformation: a report of 47 cases. Br J Haematol 1991; 77: 339-345.
34. Glucksberg H, Storb R, Fefer A. Clinical manifestations of GVHD in human recipients of marrow from HLA matched sibling donors. Transplantation 1994; 18: 295-301.
35. Souillet G, Raba M, Bertrand Y et al. Familial cord blood bank : application in children. Bone Marrow Transplant 1997; 19 (Suppl. 1): S176 (Abstr. P703).
36. Downie TR, Howset JM, Gore SM et al. A survey of use of unrelated volunteer donor bone marrow transplantation in 46 centre worldwide, 1989-1993. Bone Marrow Transplant 1995; 15: 499-503.
37. Kernan NA, Bartsh G, Ash RG et al Analysis of 462 transplantations from unrelated donors facilitated by the national marrow donor program. New Engl J Med 1993; 328: 594-602.
38. The Executive Committee of the World Marrow Donor Association. Bone marrow transplants using volunteer donors - recommendations and requirements for a standardised practice throughout the world. Bone Marrow Transplant 1992; 10: 287-291.
39. Oudshoorn M, Cornelissen JJ, Fibbe WE et al. Problems and possible solutions in finding an unrelated bone marrow donor. Results of consecutive searches for 240 Dutch patients. Bone Marrow Transplant 1997; 20: 1011-1017.
40. Beatty PG, Anasetti C, Hansen JA et al. Marrow transplantation from unrelated donors for treatment of hematological malignancies: effect of mismatching for one HLA locus. Blood 1993; 81: 249-253.
41. Petersdorf EW, Longton GM, Anasetti C et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood 1995; 86: 1606-1613.
42. Sierra J, Storer B, Hansen J et al. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching and marrow cell dose. Blood 1997; 11: 4226-4235.
43. Petersdorf EW, Longton GM, Anasetti C et al. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood 1997; 89: 1818-1823.
44. Sasazuki T, Juji T, Morishima Y et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from unrelated donor. New Engl J Med 1998; 339: 1177-1185.
45. Madrigal JA, Scott I, Arguello R et al. Factors influencing the outcome of bone marrow transplants using unrelated donors. Immunol Rev 1997; 157: 153-166.
46. Souillet G. Indications and results of progenitor cell transplantation in congenital haemopathies except Fanconi anaemia. Hématologie (in press).
47. Cornish JM, Pamphilon DH, Potter MNM et al. Unrelated donor bone marrow transplant in childhood ALL. The role of T cell depletion. Bone Marrow Transplant 1996; 18 (Suppl. 2): 31-39.
48. Hows J, Bradley BA, Gore S et al on behalf of the IMUST study. Prospective evaluation of unrelated donor bone marrow transplantation. Bone Marrow Transplant 1993; 12: 371-380.
49. Aversa F, Tabilio A, Velardi A et al. Treatment of high-risk acute leukemia with T cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. New Engl J Med 1998; 339: 1186-1193.
50. Ringdén O, Remberger M, Carlens S et al. Low incidence of acute graft-versus-host disease using unrelated HLA-A, HLA-B, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies. Transplantation 1998; 66: 620-625.
51. Nademanee A, Schmidt GM, Parker P et al. The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate and prednisone. Blood 1995; 86: 1228-1234.
52. Speiser DE, Tiercy JM, Rufer N et al. High resolution HLA matching associated with decreased mortality after unrelated bone marrow donor transplantation. Blood 1996; 86: 4455-4462.